SG/CALL/ABBOTT LABORATORIES/140/0.1/20.09.24 Share Price

Warrant

DE000SQ6C8X9

Delayed Deutsche Boerse AG 10:17:03 15/05/2024 pm IST
0.013 EUR -7.14% Intraday chart for SG/CALL/ABBOTT LABORATORIES/140/0.1/20.09.24
Current month-46.15%
1 month-80.56%
Date Price Change
15/24/15 0.013 -7.14%
14/24/14 0.014 -26.32%
13/24/13 0.019 +5.56%
10/24/10 0.018 +20.00%
09/24/09 0.015 -6.25%

Delayed Quote Deutsche Boerse AG

Last update May 15, 2024 at 10:17 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6C8X
ISINDE000SQ6C8X9
Date issued 14/12/2022
Strike 140 $
Maturity 20/09/2024 (128 Days)
Parity 10 : 1
Emission price 0.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.007
Spread 0.01
Spread %45.45%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
126.1 USD
Spread / Average Target
+21.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW